Anti-HMCES polyclonal antibody in study which suggests that HMCES is an attractive target for selective treatment of A3A-expressing lung adenocarcinoma
April, 2021 (Institute for Research in Biomedicine, Barcelona, Spain)
The capacity to repair damaged DNA may modulate individual susceptibility to develop lung cancer.
The 5-hydroxymethylcytosine binding, ESC-specific (HMCES) is the mammalian ortholog of the prokaryotic YedK protein that functions in DNA damage response. HMCES specifically enables DNA double-strand break repair.
Using our anti-HMCES polyclonal antibody (HPA044968) in Western Blot, this study suggests that HMCES is an attractive target for selective treatment of A3A-expressing lung adenocarcinoma.
Read more: http://ow.ly/rU9V50Eht2i
Anti-HMCES antibody: http://ow.ly/swuR50Eht2h